A B S T R A C T Patients with mannosidosis, an inherited deficiency of lysosomal a-mannosidase, accumulate large amounts of mannose-rich oligosaccharides (the "core" of the carbohydrate units of many glycoproteins) in brain and liver and excrete these partial degradation products in their urine. A profound a-mannosidase deficiency was demonstrated in fibroblasts cultured from a skin biopsy obtained from a child with mannosidosis. Further, abnormal glycopeptides rich in mannose and similar to oligosaccharides found in the patient's urine were isolated from fibroblast extracts by a variety of chromatographic procedures and by virtue of their binding to a concanavalin A-Sepharose 4B
A B S T R A C T Patients with mannosidosis, an inherited deficiency of lysosomal a-mannosidase, accumulate large amounts of mannose-rich oligosaccharides (the "core" of the carbohydrate units of many glycoproteins) in brain and liver and excrete these partial degradation products in their urine. A profound a-mannosidase deficiency was demonstrated in fibroblasts cultured from a skin biopsy obtained from a child with mannosidosis. Further, abnormal glycopeptides rich in mannose and similar to oligosaccharides found in the patient's urine were isolated from fibroblast extracts by a variety of chromatographic procedures and by virtue of their binding to a concanavalin A-Sepharose 4B affinity column. This storage material contained mannose, N-acetylglucosamine, and asparagine in the ratio 3: 1: 1 together with a few other amino acids and had a molecular weight of approximately 1,100. There was no evidence for excretion of storage material by mannosidosis fibroblasts or for any abnormality in cell surface glycoprotein composition. The glycopeptide nature of the storage material isolated from cultured skin fibroblasts may be attributed to the low level of N-aspartyl-P-glucosamindase (EC 3.5.1.-) activity in these cells.
INTRODUCTION
Three inherited human diseases, Gmi '-gangliosidosis (O-galactosidase deficiency) (1), GM2-gangliosidosis A preliminary report of these findings was presented at the American Society for Neurochemistry Meetings in New Orleans, March 1974 (Trans. Am. Soc. Neurochem. 5: 135, 1974) .
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Received for publication 17 January 1975 and in revised form 14 May 1975 . ' The abbreviations used in this paper: AcNeu, N-acetylneuraminic acid; Gm1, Gal j8(1 -* 3)-GalNAc , (1 ->4) type II (Sandhoff-Jatzkewitz; 8-N-acetylhexosaminidase deficiency) (2) , and fucosidosis (a-fucosidase deficiency) (3) result in defective glycosphingolipid and glycoprotein catabolism; two others, mannosidosis (a-mannosidase deficiency) (4) (Sandhoff's disease) .' An equimolar ratio of mannose and N-acetylglucosamine was also found in a mixture of oligosaccharides isolated from the urine of a patient with Sandhoff's disease (11), but no structures were proposed. Further, pentasaccharide with the structure Man-Man-Man-Man-GlcNAc (together with a related tetrasaccharide and trisaccharide) has been purified from the urine of patients with mannosidosis by Norden et al. (12) (13) (14) and in this laboratory (15) . From our present knowledge, one can envision sialo- (25) . Nonbinding material was eluted at 4VC with 50 ml of the above buffer. Bound material was eluted with 50 ml of 0.1 M a-methyl-D-mannoside in the same buffer. Both fractions were desalted on Sephadex G-10 (135 X 1.0 cm).
Their carbohydrate composition was determined by gasliquid chromatography (GLC) (26) , and radioactivity was determined by liquid scintillation counting using a TriCarb Spectrophotometer (model 3375, Packard Instrument Co., Inc., Downers Grove, Ill.) and the toluene-based counting mixture as described previously (27) . Isolation (30) .
Glycosphingolipid metabolism. Extracts of the cultured cells were assayed for lysosomal enzymes associated with glycosphingolipid metabolism as previously described (21) . Glycosphingolipids were isolated from cells cultured from skin biopsies obtained from the proband and his parents by previously published procedures and analyzed by GLC (21, 26) . Approximately 1% of the '4C-labeled complex carbohydrate material of the cell cochromatographed with the various glycolipid fractions.
RESULTS
The patient with mannosidosis (a-mannosidase de- ficiency) was first examined at the age of 6 mo by Dr. A. S. Aylsworth (University of North Carolina, Chapel Hill) because of a history of recurrent respiratory infections. At the age of 2 he showed signs of slight psychomotor retardation, some speech and hearing abnormalities, and increasing skeletal abnormalities indicative of a storage disease of the mucopoly- (15) . Enzymic analysis of extracts of skin fibroblasts cultured from the patient revealed a profound deficiency of a-mannosidase activity as the only abnormality (Table I) . a-Mannosidase activity in fibroblasts cultured from patients with mucopolysaccharide storage diseases types I through VI and related lysosomal storage diseases was found to be normal with the exception of "I-cell" disease where previous studies in many laboratories predicted the low (30% of normal) level observed. Demonstration of abnormal storage by labeling with ["C]mannose. Fibroblasts from the patient with mannosidosis, when labeled with [1'C]mannose for 4 days, incorporated 4 to 6 times as much label as did fibroblasts of comparable density and passage number from both controls, the mannosidosis heterozygote, and Hurler's disease. When ['C]mannose-labeled cell extracts from controls and the patient with mannosidosis were applied to a concanavalin A-Sepharose 4B affinity column, approximately one-third of the total label was bound in each case (Fig. 1) although the specific activity was 6 times greater in the case of mannosidosis. The amount and composition of ["C]labeled unbound material (cell glycoprotein and mucopolysaccharide) (fraction I) was the same in both normal and mannosidosis fibroblasts, but the bound material (fraction II) only contained detectable sugar in the case of mannosidosis (Table II) . Quantitative analysis of this bound material showed it to be rich in mannose 8A complete clinical summary of this patient will be published elsewhere by A. S. Aylsworth, A. Dorfman, and R. Matalon.
and to constitute 70% of the total carbohydrate (Table  II) although it contained only 33% of the radioactive label (Fig. 1) . This presumably reflects dilution by preexisting storage material. Its composition and amount are comparable to that of the storage material isolated on a larger scale by conventional chromato- (15) for the major component in the urine of this patient. Fraction IV was further purified by Bio-Gel P-2 and paper chromatography and a molecular weight estimation by Sephadex G-25 chromatography (28) (using glucose, raffinose, a GM1-gangliosidosis glycopeptide of molecular weight 1,700, and blue dextran as standards) gave a value of 1,100. A combination of sugar and amino acid analysis indicated that the material was glycopeptide in nature and contained mannose, N-acetylglucosamine, and asparagine in the ratio 3: 1: 1 (Table IV) . Incubation of this material with a-mannosidase indicated the presence of a-linked mannose as the nonreducing end-group sugar. Glucosaminylasparaginase activity in cultured cells. Cell extracts were found to have a low specific activity with respect to this carbohydrate-peptide (GlcNAcAsn) cleaving enzyme when compared to solid tissues such as kidney or other cultured cell strains such as rat astrocytoma RGC-6 (Table V) . Although some activity was detectable in vitro, the low level of activity may be related to the fact that the storage material in the cells is glycopeptide in nature whereas the urinary excretion material is mainly oligosaccharide (12) (13) (14) (15) 2 Chromatographic profiles of material isolated from a water-soluble extract of normal, mannosidosis heterozygote, Hurler's disease, and mannosidosis homozygote fibroblast cells. Cells (8 X 107) were grown in fresh modified minimal essential medium for 3 wk, harvested, frozen and thawed 3 times, and disrupted by sonication, and the 8,000 g supernatant solution was applied to a Sephadex G-50 (1.0 X 180 cm) column equilibrated with water. Fractions of 5 ml were collected, and aliquots were assayed for protein (1.0 ml) (A280 * *) and carbohydrate (0.25 ml) (phenyl sulfuric acid method, A4so 0 O). Complex carbohydrates were isolated from sonicated solution of human skin fibroblast cells (8 X 107) after growth in modified minimal essential medium for 3 wk. Four fractions were separated on Sephadex G-50 column chromatography (Fig. 2) ; fraction I represents material with the highest molecular weight.
was normal (hyaluronic acid 68%; chondroitin 4/6-sulfates, 16%; heparan sulfates, 2%; dermatan sulfate, 14%). The essentially normal levels were consistent with the absence of mucopolysacchariduria in this patient (15).
Glycosplhingolipid metabolism. Analysis of the glycosphingolipids revealed a normal pattern (21) . No evidence for mannoglycolipids was obtained, and individual glycolipids were not labeled to any significant (14, 31, 32) separable by DEAE-cellulose chromatography. In mannosidosis liver, the A and B forms (optimum pH 4.4) were shown to be absent, and the residual activity was due to the presence of the C form (optimum pH 6.0) in normal amounts. In this study, normal human skin fibroblast a-mannosidase showed pH optima at 3.5-4.0 and 6.5. a-Mannosidase activity in fibroblasts from the proband, when assayed with 4-methylumbelliferyl-a-D-mannoside, was less than 1% of normal activity at pH 3.5. The peak of activity at pH 6.0, which may be equivalent to the a-mannosidase C localized to the Golgi in human liver (33) (13, 36) in which a-mannosidase activity is greatly diminished, and the storage material (tetrasaccharide) apparently has the structure ManGlcNAc-Man-GlcNAc (13) .
The effect of the lysosomal a-mannosidase deficiency on glycoprotein metabolism was demonstrated by labeling cells with ["C]mannose and comparing the level of incorporation into mannose-rich material. Advantage was taken of the presence of terminal a-mannose residues in the storage material to achieve partial purification by affinity chromatography with concanavalin A. Concanavalin A is specific for terminal (and possibly internal) a-mannose, a-glucose, and a-GlcNAc residues, and of these only a-mannose residues are found in glycoproteins. Although the affinity column method showed a striking difference between normal and mannosidosis cells, for larger scale isolation it was found to be more convenient to isolate the low molecular weight storage material by disrupting the cells and fractionating the extract on a combination of Bio-Gel P-10 and P-2 columns. When this was done, a pure fraction containing approximately three mannose residues and one GlcNAc residue, together with 1.0 mol of asparagine and other amino acids such as glutamate, glycine, serine, and threonine, was obtained. The molecular weight was found to be 1,100 (calculated from composition as 1,150 to 1,200), and our inability to remove the amino acids suggested that it was glycopeptide in nature. The lack of material has prevented a complete characterization of the sugar sequence, and one can only infer that the linkage region involves GlcNAc and Asn linked by an amide bond by virtue of the resistance of the GIcNAc-Asn linkage to complete hydrolysis by 1.0 N HC1 in methanol at 80°C for 20 h (26, 37) . From these studies and the ability of a-mannosidase to liberate two out of three mannose residues, we can propose the structure Man a-Man a-Man P-GlcNAc-Asn-peptide for the storage material in mannosidosis fibroblasts.
The sequence (Man), (GlcNAc-GlcNAc)1 2-Asn has been reported to be the core of the oligosaccharide units of many mammalian glycoproteins (37) (38) (39) (40) , and one of the endoglycosidases which cleave the sugarpeptide bond (4-L-aspartylglucosylamine amido hydrolase) has been isolated from various tissues (41, 42) including hog kidney (43) . The endo-,8-N-acetylglucosaminidase specific for GlcNAc P( 1 >4) GlcNAcAsn has thus far only been isolated from microorganisms (44) . Measurement of N-aspartyl-,P-glucosaminidase (EC 3.5.1.-) in human skin fibroblasts indicated that activity in fibroblasts is less than 10% of that in kidney or other cultured cells such as C-6 rat astrocytoma. However, since previous in vitro studies with N-aspartyl-P-glucosaminidase from a variety of tissues have indicated that the enzyme will only act on asparaginylglycopeptides (41) (42) (43) , the observed low level of N-aspartyl-P8-glucosaminidase activity in vivo may not be the whole explanation as to why the storage material is glycopeptide in nature rather than oligosaccharide as found in other tissues and organs. It is also possible that glycopeptide storage in fibroblasts could be attributed to steric hinderance of proteolytic enzymes by the undegraded carbohydrate moiety (in this case three mannose residues and one GlcNAc residue).
In 
